•Gut microbial bile salt hydrolase as a metabolic gatekeeper in digestive homeostasis and disease
•Noncanonical NF-κB pathway driven inflammation across multiple cellular compartments identifies NIK as a therapeutic target for inflammatory bowel disease
•Mechanisms and therapeutic prospects of DNA methylation-mucosal innate immunity crosstalk in inflammatory bowel disease
•Pan-enteric Capsule Endoscopy in Crohn's Disease: Impact on Therapeutic Decisions and Inter-observer Agreement in a Multicentre Case-based Study
•Thalidomide for CGD-related inflammatory bowel disease: A randomized, double-blind trial
